Moreover, tadalafil was shown to reverse LTP reduction in slices of brain in an APP/PS1 mouse model of AD, but failed to achieve behavioral benefits when administered in vivo, probably due its poor BBB penetration [50,81]. This evidence concerns the gene APP and Alzheimer disease.